Proposal for Support for South African National Health Research Enterprise

South Africa’s national health research agency is running out of money, and this proposal asks the government for emergency funding to keep it afloat. The South African Medical Research Council (SAMRC) funds studies on diseases that disproportionately affect the country, such as tuberculosis, HIV, and maternal health complications. Without immediate financial intervention, the agency risks losing its core infrastructure—laboratories, data systems, and specialised equipment—along with the scientists who operate them. The proposal recommends a one-off emergency payment through a legal mechanism called Section 16, plus a permanent increase to the SAMRC’s baseline budget in future years. A new transparent funding process would ensure the money goes to South Africa’s most pressing health priorities. If the funding is secured, the SAMRC can continue running clinical trials, monitoring disease outbreaks, and training the next generation of researchers. This keeps the country’s health research enterprise self-sufficient rather than dependent on foreign donors. Because many infectious diseases do not respect borders, the work also benefits global health—better data from South Africa means better vaccines and treatments for everyone. The proposal is about preserving a functioning system, not launching a single experiment.